SeaStar Medical Holding Corp (ICU) Stock Analysis
Verdict: AVOID
Commercial momentum for QUELIMMUNE is building, but an acute cash runway of under 7 months makes severe equity dilution almost inevitable.
Investment score: 35/100
Analysis as of
Is SeaStar Medical Holding Corp stock worth reviewing? The TradeMates thesis
The TradeMates model assigns ICU an AVOID rating due to imminent balance sheet dilution risks despite early revenue traction for QUELIMMUNE.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 20/100 (weight 15%)
- Technical Momentum: 50/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 55/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
SeaStar Medical Holding Corp opportunities and risks
What speaks for ICU
- Pediatric hospital commercial expansion driving top-line growth.
What speaks against ICU
- Acute capital scarcity and impending equity dilution within 7 months.
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ICU | n/a | 5.9x | n/a | 92.6% | -795.5% | -134.8% |
| RDGL | n/a | 243.2x | n/a | -344.1% | -3633.3% | -10.3% |
| BEAT | n/a | 0.0x | n/a | 0.0% | 0.0% | -63.7% |
| PAVM | n/a | 149.9x | n/a | -254.5% | -10794.6% | -15637.4% |
| GTHP | n/a | 28.2x | n/a | 64.0% | -573.1% | -8.2% |
| Peer median | n/a | 89.1x | n/a | -127.2% | -2103.2% | -37.0% |
Frequently asked questions about SeaStar Medical Holding Corp (ICU)
Is ICU stock a good investment?
The TradeMates model rates SeaStar Medical Holding Corp as AVOID with an investment score of 35/100. The TradeMates model assigns ICU an AVOID rating due to imminent balance sheet dilution risks despite early revenue traction for QUELIMMUNE. This is algorithmic model output, not personal investment advice.
Is ICU stock a buy?
The TradeMates model verdict for ICU is AVOID with an investment score of 35/100. Treat this as a model signal to review, not a personal buy recommendation.